
Introduction: The present study aimed to investigate the relationship between cyberspace dependence and medication adherence, considering the mediating role of trans diagnostic constructs in patients with chronic heart failure (CHF).Methods: This descriptive-correlational study used structural equation modeling (SEM). The sample comprised 250 patients with chronic heart failure who were recruited through convenience sampling. Data were collected using the Intolerance of Uncertainty Scale (IUS-4), Acceptance and Action Questionnaire-II (AAQ-II), Mobile Social Networking Addiction Questionnaire, Morisky Medication Adherence Scale (MMAS-8), and Difficulties in Emotion Regulation Scale (DERS). Data were analyzed using Pearson correlation coefficients and SEM in SPSS and AMOS. Importantly, this instrument assesses medication-taking behavior only and was not used to measure the broader construct of heart-failure self-management.Results: The structural model demonstrated an acceptable fit to the data (χ²/df = 1.82, RMSEA = 0.058, NFI = 0.94, CFI = 0.97, IFI = 0.97, GFI = 0.93, AGFI = 0.91). The direct, indirect, and total effects require completion from the original SEM output before submission; the current manuscript does not contain sufficient information to reconstruct the missing standardized coefficients, test statistics, p-values, or bootstrap confidence intervals.Conclusion: The findings suggest that trans diagnostic constructs may help explain the association between cyberspace dependence and medication adherence among patients with chronic heart failure. Because the present study assessed medication adherence with the MMAS-8 rather than the broader construct of heart-failure self-management, conclusions should be limited to medication adherence.
Introduction: Use of an intra-aortic balloon pump (IABP) during coronary artery bypass grafting (CABG) identifies a high-risk subgroup with substantial perioperative mortality. Determinants of outcome in this setting remain incompletely defined, particularly regarding hemodynamic severity and intraoperative timing of IABP insertion relative to cardiopulmonary bypass (CPB). We aimed to identify independent predictors of in-hospital mortality among CABG patients requiring IABP support and to evaluate whether the intraoperative interval between CPB separation and IABP insertion influences outcome.Methods: A retrospective analysis of CABG patients supported with IABP was performed. 113 patients who underwent on-pump CABG with IABP between March 2020 and March 2025 were included. Baseline characteristics, operative variables—including CPB time and precise intraoperative IABP timing—and postoperative outcomes were recorded. Multivariate logistic regression was used to identify independent predictors of mortality.Results: In-hospital mortality was high and consistent with previously reported surgical IABP cohorts. Lower preoperative ejection fraction, prolonged CPB duration, and higher inotrope requirement independently predicted mortality, indicating that outcome was primarily driven by myocardial dysfunction, bypass-related stress, and persistent hemodynamic instability. Sex was associated with mortality but was not a primary determinant of risk. The interval between CPB weaning and IABP initiation did not show statistical significance; however, interpretation was limited by substantial missing data and restricted variability in recorded timings.Conclusion: Among CABG patients requiring IABP, early mortality is determined mainly by the severity of ventricular dysfunction, operative complexity, and residual circulatory failure rather than by IABP use itself. Although the intraoperative timing of IABP relative to CPB separation was not statistically significant in this study, methodological limitations prevent ruling out a clinically significant effect. Prospective studies with precise, complete intraoperative timing data are needed to define optimal timing and refine risk stratification.
Aortic mural thrombus occurring in a non-aneurysmal, non-dissected aorta is a relatively rare entity. The presentation is variable, and aortic mural thrombus may be asymptomatic or present with emboli or ischemia. We present a case of a 77-year-old man admitted with urinary retention, who was found on examination to have a significant inter-arm blood pressure difference and a reduced right radial pulse. Computed tomography angiography (CTA) was performed and identified the presence of an aortic arch mural thrombus extending into the brachiocephalic trunk, left common carotid artery, and left subclavian artery. No dissection or aneurysm was detected. As there was no evidence of emboli, distal embolization, or ischemia, the patient was treated with anticoagulants. Three months later, the patient remains well with resolution of the radial pulse and inter-arm blood pressure difference; however, repeat CTA was refused, and resolution of the thrombus could not be confirmed. This case highlights the importance of careful general examination in patients presenting with non-vascular complaints and suggests conservative anticoagulation as a treatment modality for aortic mural thrombus in the absence of emboli or ischemia.
Introduction: Prosthetic valve thrombosis (PVT) is a potentially life-threatening complication of mechanical heart valves, particularly when affecting left-sided valves. Management requires rapid and precise assessment, balancing the risks and benefits of thrombolysis versus surgical intervention, especially in high-risk patients.Case Presentation: We report the case of a 64-year-old Iranian female with a history of mechanical aortic and mitral valve replacement (2019), chronic atrial fibrillation, and a recent cerebrovascular accident (October 2024), who presented with rapidly worsening dyspnea and pulmonary edema. Initial workup revealed atrial fibrillation with rapid ventricular response and signs of cardiogenic shock. Imaging confirmed mechanical aortic valve thrombosis with subtherapeutic international normalized ratio (INR) levels. Echocardiography demonstrated a severely reduced ejection fraction (20–25%), left ventricular enlargement, and hemodynamic evidence of prosthetic valve obstruction. Given her New York Heart Association (NYHA) Class IV status and significant surgical risk due to low Ejection Fraction (EF) and recent stroke, slow-infusion fibrinolytic therapy with alteplase was initiated as an alternative to surgery. The patient showed remarkable clinical and echocardiographic improvement, with resolution of pulmonary edema and restoration of normal valve leaflet motion. She was stabilized on anticoagulation therapy and discharged in good condition.Conclusion: This case highlights the challenges in managing obstructive mechanical valve thrombosis in patients with high surgical risk and recent cerebrovascular events. Slow-infusion thrombolytic therapy may be a viable and effective alternative in carefully selected patients.
Introduction: From 2010 onwards, guidelines, including those of the British Thoracic Society (BTS), recommend the use of ultrasound in all pleural fluid evaluation procedures. There are various established formulas to estimate the pleural fluid volume using ultrasonography. The two formulas by Goecke and Schwerk, Einberger’s formula, Balik’s formula, and Usta’s formula are some of the most commonly used ones. But considering only a single or a couple of measurements to estimate the total volume of pleural effusion, especially moderate to large effusions, will definitely have its own disadvantages. The objective of the PLEURA 1 study was to develop a new multi- site ultrasound-based model for a more accurate estimation of the pleural fluid volume and to compare it with the existing formulae.Materials and Methods: PLEURA 1, a prospective observational study, was conducted in a tertiary care center in South India. A novel multisite parameter (Mean9) was defined using nine different ultrasonographic dimensions. Pearson correlation coefficients (r) were calculated to assess the strength of association between predicted and actual pleural fluid volume. Model performance was assessed using the coefficient of determination (R²), mean absolute error (MAE), and root mean square error (RMSE) and compared with that of the existing erect position formulas.Results: The study cohort consisted of twenty-four patients with pleural effusion. Mean9 demonstrated a strong linear relationship with actual pleural fluid volume (Pearson r = 0.853, 95% CI 0.68–0.94; p < 0.0001). ‘Paul’s formula’, ‘V = 41.4 + 270.8 × Mean9’ was derived using linear regression. Paul’s formula maintained the highest predictive performance among all evaluated models (LOOCV r = 0.820, LOOCV R² = 0.672, MAE = 422 mL, RMSE = 504 mL), and demonstrated better correlation to actual pleural fluid volume than the established erect-position formulas.Conclusion: PLEURA 1 study and Paul’s formula suggest that incorporating multiple dimensions of the pleural effusion into a predictive model may improve the estimation of pleural fluid volume. PLEURA 2 validation study will be the second phase of the study, where Paul’s formula will be applied along with other established formulae in an entirely new and larger cohort.